Pay in 4 interest-free payments of $31.24 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
CAS Number: 2114339-57-8
GW 791343 is an antagonist with similar potency to that determined at the human receptor
improvement of bone mineral density
and molecular defects of two otherwise unrelated protein-misfolding diseases in mice
InChi: InChI=1S/C20H23N3O3/c1-22(2)11-13-8-19(26-5)15(9-18(13)25-4)17-12-23(3)20(24)16-10-21-7-6-14(16)17/h6-10
Miglustat Hydrochloride 240551 CAS Number: 2114339-57-8Miglustat, also known as OGT 918 and NB DNJ, is a drug developed by Actelion and is used primarily to treat Type I Gaucher disease (GD1). Miglustat inhibits glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids (it forms glucosylceramide and accumulates within the macrophages). Miglustat is used to treat adults with mild to moderate Type I Gaucher disease and it is the first treatment to be approved for patients
US$ 1450.00
US$ 1200.00
US$ 50.99
US$ 750.00
US$ 1400.00
US$ 625.00
US$ 625.00
US$ 21.03
US$ 625.00
US$ 1400.00
US$ 1750.00
US$ 625.00
US$ 20.00
US$ 60.00
US$ 28.89